Ascorbic acid-2 glucoside mitigates intestinal damage during pelvic radiotherapy in a rat bladder tumor model

References

• Ahmed EA, Agay D, Schrock G, Drouet M, Meineke V, Scherthan H. 2012. Persistent DNA damage after high dose in vivo gamma exposure of minipig skin. PLoS One. 7(6):e39521.
   PubMed Web of Science ®Google Scholar
• Andreyev J. 2007. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol. 8(11):1007–1017.
   PubMed Web of Science ®Google Scholar
• Barros MH, Hauck F, Dreyer JH, Kempkes B, Niedobitek G. 2013. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLOS One. 8(11):e80908.
   PubMed Web of Science ®Google Scholar
• Cai L, Koropatnick J, Cherian MG. 2001. Roles of vitamin C in radiation-induced DNA damage in presence and absence of copper. Chem Biol Interact. 137(1):75–88.
   PubMed Web of Science ®Google Scholar
• Cameron E, Pauling L, Leibovitz B. 1979. Ascorbic acid and cancer: a review. Cancer Res. 39(3):663–681.
   PubMed Web of Science ®Google Scholar
• Chandrasekharan DK, Kagiya TV, Nair CK. 2009. Radiation protection by 6-palmitoyl ascorbic acid-2-glucoside: studies on DNA damage in vitro, ex vivo, in vivo and oxidative stress in vivo. J Radiat Res. 50(3):203–212.
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. 2019. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 26(1):78.
   PubMed Web of Science ®Google Scholar
• Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S. 1979. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med. 301(13):687–690.
   PubMed Web of Science ®Google Scholar
• Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Bénazeth S, Cynober L. 2005. Almost all about citrulline in mammals. Amino Acids. 29(3):177–205.
   PubMed Web of Science ®Google Scholar
• Gonzalez MJ, Miranda-Massari JR, Mora EM, Guzman A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Roman-Franco A. 2005. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 4(1):32–44.
   PubMedGoogle Scholar
• Henson DE, Block G, Levine M. 1991. Ascorbic acid: biologic functions and relation to cancer. J Natl Cancer Inst. 83(8):547–550.
   PubMedGoogle Scholar
• Ito Y, Kinoshita M, Yamamoto T, Sato T, Obara T, Saitoh D, Seki S, Takahashi Y. 2013. A combination of pre- and post-exposure ascorbic acid rescues mice from radiation-induced lethal gastrointestinal damage. Int J Mol Sci. 14(10):19618–19635.
   PubMed Web of Science ®Google Scholar
• Iwai A, Koga F, Fujii Y, Masuda H, Saito K, Numao N, Sakura M, Kawakami S, Kihara K. 2011. Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomy. Jpn J Clin Oncol. 41(12):1373–1379.
   PubMed Web of Science ®Google Scholar
• Koga F, Kihara K, Yoshida S, Yokoyama M, Saito K, Masuda H, Fujii Y, Kawakami S. 2012. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU Int. 109(6):860–866.
   PubMed Web of Science ®Google Scholar
• Latvala S, Jacobsen B, Otteneder MB, Herrmann A, Kronenberg S. 2017. Distribution of FcRn across species and tissues. J Histochem Cytochem. 65(6):321–333.
   PubMed Web of Science ®Google Scholar
• Mikirova N, Casciari J, Riordan N, Hunninghake R. 2013. Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients. J Transl Med. 11:191.
   PubMed Web of Science ®Google Scholar
• Miyazaki K, Morimoto Y, Nishiyama N, Satoh H, Tanaka M, Shinomiya N, Ito K. 2014. Preconditioning methods influence tumor property in an orthotopic bladder urothelial carcinoma rat model. Mol Clin Oncol. 2(1):65–70.
   PubMedGoogle Scholar
• Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. 1985. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 312(3):137–141.
   PubMed Web of Science ®Google Scholar
• Mortazavi SM, Rahimi S, Mosleh-Shirazi MA, Arjomandi M, Soleimani A, Koohi Hossein-Abadi O, Haghani M, Alavi M. 2015. A comparative study on the life-saving radioprotective effects of vitamins A, E, C and over-the-counter multivitamins. J Biomed Phys Eng. 5(2):59–66.
   PubMedGoogle Scholar
• Murad S, Grove D, Lindberg KA, Reynolds G, Sivarajah A, Pinnell SR. 1981. Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci USA. 78(5):2879–2882.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Oku T. 2009. Bioavailability of 2-O-alpha-d-glucopyranosyl-l-ascorbic acid as ascorbic acid in healthy humans. Nutrition. 25(6):686–691.
   PubMed Web of Science ®Google Scholar
• Olkhov-Mitsel E, Hodgson A, Liu SK, Vesprini D, Bayani J, Bartlett JMS, Xu B, Downes MR. 2020. Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer? Pathol Res Pract. 216(11):153200.
   PubMed Web of Science ®Google Scholar
• Ottoboni F, Ottoboni A. 2005. Ascorbic acid and the immune system. J Orthomol Med. 20(3):179–183.
   Google Scholar
• Sato T, Kinoshita M, Yamamoto T, Ito M, Nishida T, Takeuchi M, Saitoh D, Seki S, Mukai Y. 2015. Treatment of irradiated mice with high-dose ascorbic acid reduced lethality. PLOS One. 10(2):e0117020.
   PubMed Web of Science ®Google Scholar
• Simone CB 2nd, Simone NL, Simone V, Simone CB. 2007. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med. 13(1):22–28.
   PubMed Web of Science ®Google Scholar
• Solinas G, Germano G, Mantovani A, Allavena P. 2009. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol. 86(5):1065–1073.
   PubMed Web of Science ®Google Scholar
• Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW, Friedlander T, et al. 2017. Bladder cancer, version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 15(10):1240–1267.
   PubMed Web of Science ®Google Scholar
• Stacey R, Green JT. 2014. Radiation-induced small bowel disease: latest developments and clinical guidance. Ther Adv Chronic Dis. 5(1):15–29.
   PubMedGoogle Scholar
• Takeuchi H, Tanaka M, Tanaka A, Tsunemi A, Yamamoto H. 2016. Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness. Oncol Lett. 11(5):3403–3408.
   PubMed Web of Science ®Google Scholar
• Tidball JG, Villalta SA. 2010. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol. 298(5):R1173–R1187.
   PubMed Web of Science ®Google Scholar
• Tsuji Y, Kuramochi M, Golbar HM, Izawa T, Kuwamura M, Yamate J. 2020. Acetaminophen-induced rat hepatotoxicity based on M1/M2-macrophage polarization, in possible relation to damage-associated molecular patterns and autophagy. Int J Mol Sci. 21(23):8998.
   Web of Science ®Google Scholar
• Yamamoto T, Kinoshita M, Shinomiya N, Hiroi S, Sugasawa H, Matsushita Y, Majima T, Saitoh D, Seki S. 2010. Pretreatment with ascorbic acid prevents lethal gastrointestinal syndrome in mice receiving a massive amount of radiation. J Radiat Res. 51(2):145–156.
   PubMed Web of Science ®Google Scholar
• Ye F, Ning J, Fardous Z, Katsube T, Li Q, Wang B. 2020. Citrulline, a potential biomarker of radiation-induced small intestine damage. Dose Response. 18(3):1559325820962341.
   Web of Science ®Google Scholar